Volume 17, Number 12—December 2011
Novel Astroviruses in Children, Egypt
Highlight and copy the desired format.
|EID||Ahmed SF, Sebeny PJ, Klena JD, Pimentel G, Mansour A, Naguib AM, et al. Novel Astroviruses in Children, Egypt. Emerg Infect Dis. 2011;17(12):2391-2393. https://dx.doi.org/10.3201/eid1712.110909|
|AMA||Ahmed SF, Sebeny PJ, Klena JD, et al. Novel Astroviruses in Children, Egypt. Emerging Infectious Diseases. 2011;17(12):2391-2393. doi:10.3201/eid1712.110909.|
|APA||Ahmed, S. F., Sebeny, P. J., Klena, J. D., Pimentel, G., Mansour, A., Naguib, A. M....Wang, D. (2011). Novel Astroviruses in Children, Egypt. Emerging Infectious Diseases, 17(12), 2391-2393. https://dx.doi.org/10.3201/eid1712.110909.|
To the Editor: Human astroviruses (HAstVs) are a common cause of gastroenteritis in children, the elderly, and immunocompromised persons (1). Up to 10% of acute viral gastroenteritis in children and 0.5%–15% of diarrheal outbreaks are attributed to astroviruses (2). Until 2008, eight classical astrovirus serotypes were known to cause human disease; in Egypt, HAstV-1 is the most frequent astrovirus serotype detected (3). Recently, 5 novel astroviruses have been discovered in human fecal samples from patients with diarrhea or acute flaccid paralysis (4–7). Because the prevalence of these virsues in the Middle East is unknown, we screened fecal samples from children with diarrhea residing in Egypt to ascertain the prevalence and diversity of these novel astroviruses.
Fecal samples were collected from a cohort of 364 symptomatic children <5 years of age who had diarrhea and were seeking medical care at Abu Homos Hospital in the Nile Delta of Egypt from September 2006 through September 2007. RNA was extracted from 10% fecal suspensions and reverse transcription PCR for astrovirus was performed as previously described (4–6). Astrovirus consensus primer pair SF0073/SF0076 amplified an ≈409-bp region of open reading frame (ORF) 1b, encoding the RNA polymerase gene. PCR-positive samples were then tested by using primer sets Mon269–Mon270 (8) and SF0053–SF0061, amplifying either a 449-bp or a 402-bp product of the ORF2 capsid gene from classical HAstVs (serotypes I–VIII) or astrovirus MLB1, respectively. DNA sequences of PCR products were determined by using Big Dye Terminator Cycle technology (Applied Biosystems, Foster City, CA, USA). Nucleotide sequences were compared with sequences obtained from GenBank. Phylogenies were constructed with the MEGA4 software (www.megasoftware.net) by using the neighbor-joining method and a p-distance algorithm. Bootstrap resampling was performed by using 2,000 replicates to demonstrate robustness of grouping. The nucleotide sequences determined in this study were assigned GenBank accession nos. HQ674630–HQ674650.
Consensus astrovirus reverse transcription PCR results were positive in 23 (6.3%) of 364 fecal samples. Five common serotypes of classical HAstV were identified constituting 16 (70%) of 23 positive samples; HAstV type I was most prevalent (n = 9). Alignment of the partial amino acid sequences of the ORF2 capsid region indicates that Egyptian HAstV type I strains share 99%–100% identity (Figure, panel A).
Five of the 7 remaining positive samples were most closely related to MLB1 on the basis of the partial ORF2 sequence analysis. Egypt MLB1 samples shared ≈99%-nt identity with each other, and all grouped in 1 phylogenetic cluster (Figure, panel B) along with a recently identified MLB1 strain (GenBank accession no. HM450380 ) isolated from a human fecal sample in Hong Kong. The Egypt MLB1 strains shared ≈97%-nt identity with the prototype MLB1 Australia strain but were more divergent from an isolate recently described in the United States (92% nt identity, GenBank accession no. FJ222451). However, all of the observed nucleotide differences represented silent mutations between Egypt MLB1 and Australia and US isolates; comparison of partial capsid protein sequences indicated no amino acid changes.
The 2 remaining HAstV-positive samples were phylogenetically most similar to astrovirus VA2 (VA2) (Figure, panel B). On the basis of the sequence of the amplicon from the ORF1b region, the Egyptian VA2 isolates shared 96.1%–100% aa identity to previously described VA2 and astrovirus human/mink/ovine genomes in GenBank.
Our study describes the detection of the recently identified viruses MLB1 and VA2 in a cohort of symptomatic children with diarrhea residing in Egypt. This study expands the geographic range of these viruses to include northern Africa. The consensus primers used in our study were able to detect a higher percentage of positive HAstV serotypes I–VIII than the Mon340/Astman-2 primers (10) (data not shown), a finding that encourages use of these primers to screen humans with gastroenteritis for astroviruses. Increased understanding of the genetic diversity within viral families infecting humans will assist in future studies of their pathogenicity and the design of specific diagnostic assays. Further epidemiologic studies, including clinical cases and demographically matched healthy controls, are required to better define their pathogenic potential.
This work was supported by the Global Emerging Infections and Surveillance System, a Division of the Armed Forces Health Surveillance Center and in part by the National Institutes of Health under KL2 RR024994. The study protocol DOD NAMRU3.2000.0002 (IRB Protocol No. 096) was hospital-based surveillance for enteric pathogens associated with severe diarrhea in Egyptian children.
- Klein EJ, Boster DR, Stapp JR, Wells JG, Qin X, Clausen CR, Diarrhea etiology in a children’s hospital emergency department: a prospective cohort study. Clin Infect Dis. 2006;43:807–13.
- Lyman WH, Walsh JF, Kotch JB, Weber DJ, Gunn E, Vinje J. Prospective study of etiologic agents of acute gastroenteritis outbreaks in child care centers. J Pediatr. 2009;154:253–7.
- Naficy AB, Rao MR, Holmes JL, Abu-Elyazeed R, Savarino SJ, Wierzba TF, Astrovirus diarrhea in Egyptian children. J Infect Dis. 2000;182:685–90.
- Finkbeiner SR, Kirkwood CD, Wang D. Complete genome sequence of a highly divergent astrovirus isolated from a child with acute diarrhea. Virol J. 2008;5:117.
- Finkbeiner SR, Holtz LR, Jiang Y, Rajendran P, Franz CJ, Zhao G, Human stool contains a previously unrecognized diversity of novel astroviruses. Virol J. 2009;6:161.
- Finkbeiner SR, Li Y, Ruone S, Conrardy C, Gregoricus N, Toney D, Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis. J Virol. 2009;83:10836–9.
- Kapoor A, Li L, Victoria J, Odernide B, Mason C, Pandey P, Multiple novel astrovirus species in human stool. J Gen Virol. 2009;90:2965–72.
- Noel JS, Lee TW, Kurtz JB, Glass RI, Monroe SS. Typing of human astroviruses from clinical isolates by enzyme immunoassay and nucleotide sequencimg. J Clin Microbiol. 1995;33:797–801.
- Chu DK, Chin AW, Smith GJ, Chan KH, Guan Y, Peiris JS, Detection of novel astroviruses in urban brown rats and previously known astroviruses in humans. J Gen Virol. 2010;10:2457–62.
- Rohayem J, Berger S, Juretzek T, Herchenroder O, Mogel M, Poppe M, A simple and rapid single-step m-RT-PCR to detect norovirus, astrovirus and adenovirus in clinical stool samples. J Virol Methods. 2004;118:49–59.
- Figure. A) Phylogenetic analysis of the partial amino acid sequences of the open reading frame (ORF) 2 capsid region of human astrovirus (HAstV) types I–VIII (using Mon primer) with other sequences...
Please use the form below to submit correspondence to the authors or contact them at the following address:
Salwa F. Ahmed, US Naval Medical Research Unit No. 3 (NAMRU-3), PSC 452 Box 5000, FPO AE 09835, USA
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: November 18, 2011
- Page last updated: November 18, 2011
- Page last reviewed: November 18, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)